We were downsizing, simplifying, really, and with that came the familiar rhythm of sorting, deciding, letting go. By now, we had done this enough to know the routine: keep what matters, release what ...

When your skin senses UV radiation, melanocytes, the cells responsible for pigment, produce melanin as a shield to protect ...

Dr. Thomas Flaig highlights the importance of multidisciplinary care and clinical trials in guiding personalized bladder ...

The latest episode of the "Breast Cancer Briefing" podcast highlights the evolving integration of GLP-1 agonists into the breast cancer treatment armamentarium. Join Dr. Sara Nunnery, Director of ...

A new clinical trial is enrolling up to 60 children and young people with solid tumors across the United States and United ...

An expert discusses the need to tailor treatment duration in bladder cancer, balancing improved outcomes with toxicity and ...

Multiple myeloma research led by researchers at the University of Calgary identified how tumor cells adapt after ...

Darlifarnib is an investigational next-generation farnesyl transferase inhibitor designed to interfere with cellular pathways ...

Tamera Anderson-Hanna reflects on survivorship, redefining life with family, travel, purpose and giving back while embracing ...

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

SP16 is an investigational intravenous therapy designed to treat chemotherapy-induced pain and peripheral neuropathy, also ...

After an aggressive breast cancer diagnosis, psychologist Loraine Alderman retires to bridge gaps in patient literature ...